{
  "question_id": "onvdx24002",
  "category": "on",
  "category_name": "Oncology",
  "educational_objective": "Diagnose lung cancer with PET/CT scan.",
  "metadata": {
    "care_types": [],
    "patient_types": [],
    "high_value_care": false,
    "hospitalist": false,
    "question_updated": "12/31/2025"
  },
  "question_text": "A 67-year-old woman is evaluated for a lung mass.PET/CT scan is shown.",
  "question_stem": "Which of the following is the most likely diagnosis?",
  "options": [
    {
      "letter": "A",
      "text": "Hamartoma",
      "peer_percentage": 0
    },
    {
      "letter": "B",
      "text": "Lung cancer",
      "peer_percentage": 0
    },
    {
      "letter": "C",
      "text": "Pulmonary arteriovenous malformation",
      "peer_percentage": 0
    },
    {
      "letter": "D",
      "text": "Rounded atelectasis",
      "peer_percentage": 0
    }
  ],
  "user_performance": {
    "user_answer": null,
    "correct_answer": "B",
    "result": null,
    "time_taken": null
  },
  "critique": "The most likely diagnosis is lung cancer (Option B). PET/CT is a standard component of initial staging for all patients with nonâ€“small cell lung cancer and is useful for assessing mediastinal nodes and identifying distant metastatic disease. This patient's PET/CT scan shows enhanced uptake of the 18-fluorodeoxyglucose marker (seen as red on the image), indicating increased metabolic activity consistent with high likelihood of malignancy. Abnormal 18-fluorodeoxyglucose uptake is not seen elsewhere on the scan. Resection of this lesion showed an adenocarcinoma with no evidence of spread to hilar or mediastinal nodes.",
  "critique_links": [],
  "key_points": [],
  "references": "",
  "related_content": {
    "syllabus": [
      "onsec24004_24002"
    ],
    "learning_plan_topic": ""
  },
  "media": {
    "tables": [],
    "images": [],
    "svgs": [],
    "videos": []
  },
  "media_metadata": null,
  "extracted_at": "2025-12-31T17:07:58.199046-06:00"
}